Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
The latest announcement is out from Arbutus Biopharma ( (ABUS) ).
Michael J. Sofia is set to retire as the Chief Scientific Officer of Arbutus Biopharma, Inc. by the end of 2024, and an amendment to his employment agreement has been made regarding his retirement benefits and post-retirement activities. The amendment ensures that Dr. Sofia will receive his annual bonus for 2024 and clarifies the scope of activities he can engage in after retirement, in line with his non-compete obligations.
See more insights into ABUS stock on TipRanks’ Stock Analysis page.
